<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="brief-report" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microbiol Spectr</journal-id><journal-id journal-id-type="iso-abbrev">Microbiol Spectr</journal-id><journal-id journal-id-type="pmc-domain-id">3931</journal-id><journal-id journal-id-type="pmc-domain">microbiolspectr</journal-id><journal-id journal-id-type="publisher-id">spectrum</journal-id><journal-title-group><journal-title>Microbiology Spectrum</journal-title></journal-title-group><issn pub-type="epub">2165-0497</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12502691</article-id><article-id pub-id-type="pmcid-ver">PMC12502691.1</article-id><article-id pub-id-type="pmcaid">12502691</article-id><article-id pub-id-type="pmcaiid">12502691</article-id><article-id pub-id-type="pmid">40879403</article-id><article-id pub-id-type="doi">10.1128/spectrum.00590-25</article-id><article-id pub-id-type="publisher-id">spectrum00590-25</article-id><article-id pub-id-type="publisher-id">spectrum.00590-25</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Observation</subject></subj-group><subj-group subj-group-type="article-attributes"><compound-subject><compound-subject-part content-type="code">open-peer-review</compound-subject-part><compound-subject-part content-type="label">Open Peer Review</compound-subject-part></compound-subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">antimicrobial-chemotherapy</compound-subject-part><compound-subject-part content-type="label">Antimicrobial Chemotherapy</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Killing of colistin-resistant <italic toggle="yes">Aeromonas hydrophila</italic> by a synthetic peptide</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0358-1421</contrib-id><name name-style="western"><surname>Sun</surname><given-names initials="L">Leisheng</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Jiang</surname><given-names initials="Z">Zonghan</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="D">Dingding</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tian</surname><given-names initials="Y">Yao</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="J">Junqi</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6612-6541</contrib-id><name name-style="western"><surname>Sun</surname><given-names initials="Z">Zhiliang</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="cor1" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role><email>sunzhiliang1965@aliyun.com</email></contrib><aff id="aff1"><label>1</label><institution-wrap><institution>Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy, School of Medicine, Hunan Normal University</institution><institution-id institution-id-type="ringgold">12568</institution-id><institution-id institution-id-type="ror">https://ror.org/053w1zy07</institution-id></institution-wrap>, <city>Changsha</city>, <country>PR China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution>Hunan Provincial Key Laboratory of Anti-Resistance Microbial Drugs, The Third Hospital of Changsha</institution><institution-id institution-id-type="ringgold">610055</institution-id><institution-id institution-id-type="ror">https://ror.org/04w3qme09</institution-id></institution-wrap>, <city>Changsha</city>, <country>PR China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution>Hunan Engineering Research Center of Livestock and Poultry Health Care, College of Veterinary Medicine, Hunan Agricultural University</institution><institution-id institution-id-type="ringgold">12575</institution-id><institution-id institution-id-type="ror">https://ror.org/01dzed356</institution-id></institution-wrap>, <city>Changsha</city>, <country>PR China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution>Hunan Institute of Animal and Veterinary Science, Hunan Academy of Agricultural Sciences</institution><institution-id institution-id-type="ringgold">441102</institution-id><institution-id institution-id-type="ror">https://ror.org/01fj5gf64</institution-id></institution-wrap>, <city>Changsha</city>, <country>PR China</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name name-style="western"><surname>Lin</surname><given-names initials="J">Jinshui</given-names></name><aff><institution-wrap><institution>Yan'an University</institution></institution-wrap>, <city>Yan'an</city>, <state>Shaanxi</state>, <country>China.</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><role>Peer Reviewer</role><name name-style="western"><surname>Bao</surname><given-names initials="R">Rui</given-names></name><aff><institution-wrap><institution>Sichuan University</institution></institution-wrap>, <city>Chengdu</city>, <country>China</country></aff></contrib><contrib contrib-type="reviewer"><role>Peer Reviewer</role><name name-style="western"><surname>Taheri-Araghi</surname><given-names initials="S">Sattar</given-names></name><aff><institution-wrap><institution>California State University Northridge</institution></institution-wrap>, <city>Northridge</city>, <state>California</state>, <country>USA</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Zhiliang Sun, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:sunzhiliang1965@aliyun.com">sunzhiliang1965@aliyun.com</email></corresp><fn fn-type="equal"><p>Leisheng Sun and Zonghan Jiang contributed equally to this article. Author order was determined both alphabetically and in order of increasing seniority.</p></fn><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection"><month>10</month><year>2025</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>8</month><year>2025</year></pub-date><volume>13</volume><issue>10</issue><issue-id pub-id-type="pmc-issue-id">498474</issue-id><elocation-id>e00590-25</elocation-id><history><date date-type="received"><day>26</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>13</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>29</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>08</day><month>10</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-10-08 10:25:16.343"><day>08</day><month>10</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 Sun et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Sun et al.</copyright-holder><ali:free_to_read start_date="2025-08-29"/><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="spectrum.00590-25.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="spectrum.00590-25.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="reviewer_comments" xlink:href="reviewer-comments.pdf"/><abstract abstract-type="primary"><title>ABSTRACT</title><p>Multi-drug-resistant <italic toggle="yes">Aeromonas hydrophila</italic> infections are becoming increasingly threatening, and the development of novel antimicrobial drugs is indispensable. Herein, we demonstrate that this novel peptide is highly active against colistin-resistant <italic toggle="yes">A. hydrophila</italic> strain and shows sustained killing efficacy <italic toggle="yes">in vivo</italic>. Mechanistic studies showed that D-Q7 interacted with phosphatidylglycerol and lipopolysaccharide in the bacterial cell membrane, with an increase in intracellular ROS as well as a decrease in ATP level, ultimately leading to cell membrane disruption and bacterial death. Importantly, our study identified gene3832 as a potential regulator of membrane permeability, which may act as a potential modulator of bacterial susceptibility to D-Q7. The role of gene3832 was further confirmed by gene knockout and complementation assays. Consistently, we observed that gene3832 was also involved in biofilm formation in the colistin-resistant <italic toggle="yes">A. hydrophila</italic> strain. Collectively, our study provides an effective antimicrobial strategy with potential targets for the treatment of drug-resistant <italic toggle="yes">A. hydrophila</italic> infection.</p><sec><title>IMPORTANCE</title><p>As an environmental, zoonotic pathogen, <italic toggle="yes">Aeromonas hydrophila</italic> remains a major pathogenic bacterium, bringing large economic losses and eco-environmental pressure during the event of large-scale infection. Currently, the occurrence of colistin-resistant <italic toggle="yes">A. hydrophila</italic> poses a threat to public health owing to the lack of effective prevention and therapeutics. D-Q7 is a D-type antimicrobial peptide (AMP) with potent sterilization activity against gram-negative ESKAPE pathogens; it is thus of considerable interest to evaluate whether D-Q7 represents a promising therapeutic candidate against this pathogen. Consequently, we found that D-Q7 was a potent antibacterial agent that killed colistin-resistant <italic toggle="yes">A. hydrophila 23-c-23 in vitro</italic> and in a mouse epicutaneous model of <italic toggle="yes">23-c-23</italic> infection. In addition, we found that <italic toggle="yes">gene3832</italic>, as a potential transmembrane autotransporter, is related to bacterial resistance to D-Q7. Importantly, our study here will help guide the future design and optimization of novel AMPs to combat colistin-resistant <italic toggle="yes">A. hydrophila</italic>.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd><italic toggle="yes">Aeromonas hydrophila</italic></kwd><kwd>antimicrobial agents</kwd><kwd>drug resistance</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award-1"><funding-source><institution-wrap><institution>The Hunan Provincial Key Laboratory of Anti-ResistanceMicrobial Drugs, the Third Hospital of Changsha</institution></institution-wrap></funding-source><award-id>2023TP1013</award-id><principal-award-recipient><name name-style="western"><surname>Sun</surname><given-names>Leisheng</given-names></name></principal-award-recipient></award-group><award-group award-type="grant" id="award-2"><funding-source><institution-wrap><institution>Natural Science Foundation of Hunan Province</institution></institution-wrap></funding-source><award-id>2023JJ30301</award-id><principal-award-recipient><name name-style="western"><surname>Sun</surname><given-names>Zhiliang</given-names></name></principal-award-recipient></award-group></funding-group><counts><count count="1" count-type="supplementary-material"/><count count-type="authors" count="6"/><fig-count count="2"/><table-count count="1"/><equation-count count="0"/><ref-count count="18"/><page-count count="9"/><word-count count="5007"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>October 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>OBSERVATION</title><p><italic toggle="yes">Aeromonas hydrophila</italic> is characterized as one of the main pathogens of fish and other marine animals, leading to notorious outbreaks in aquaculture systems because of their wide distribution in aquatic environments (<xref rid="B1" ref-type="bibr">1</xref>). Besides, pathological processes generated by these opportunistic bacteria are frequently reported in immunosuppressed patients. Several virulence factors in this pathogen, including lipases, proteases, hemolysins, aerolysins, cytotoxins, and enterotoxins, are shown to play roles in the survival and environmental adaptation as well as infectious processes (<xref rid="B2" ref-type="bibr">2</xref>). Due to the overuse of various antibiotics, <italic toggle="yes">A. hydrophila</italic>, as natural inhabitants of the ecosystems, has acquired antibiotic resistance against a variety of beta-lactams (<xref rid="B3" ref-type="bibr">3</xref>). More seriously, colistin, the last resort against multi-drug resistant (MDR) microorganisms, was reported to show low potency to kill some <italic toggle="yes">A. hydrophila</italic> strains isolated from clinical samples or developed by lab culture (<xref rid="B4" ref-type="bibr">4</xref>). Therefore, the discovery of new agents, which are potent to sterilize colistin-resistant <italic toggle="yes">A. hydrophila</italic>, is necessary.</p><p>Membrane-permeabilizing antimicrobial peptides (AMPs) are known as a promising and effective strategy to treat bacterial infections, especially caused by drug-resistant strains (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Although thousands of AMPs have been discovered with high potency and broad-spectrum antimicrobial activity against bacteria, the toxicity and instability <italic toggle="yes">in vivo</italic> impede more investigations and further clinical trials (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). Previously, a broad-spectrum, host cell-compatible antimicrobial peptide called D-CONGA (<underline>D</underline>-amino acid <underline>con</underline>sensus with <underline>g</underline>lycine <underline>a</underline>bsent; amino acid sequence: rrwarrlafafrr-amide) was screened and identified by synthetic molecular evolution from a peptide library containing 28,000 members (<xref rid="B9" ref-type="bibr">9</xref>). Subsequently, D-CONGA was modified with a polar glutamine inserted between the cationic and hydrophobic segments. This new variant, called D-Q7, showed a broader antimicrobial spectrum, improved antibiotic and antibiofilm activity with even lower residual toxicity compared to its parent peptide, D-CONGA (<xref rid="B10" ref-type="bibr">10</xref>). Therefore, it is encouraging to investigate whether D-Q7 is a potential candidate AMP against colistin-resistant <italic toggle="yes">A. hydrophila</italic>.</p><p>To study the colistin-resistant <italic toggle="yes">A. hydrophila</italic> strain, we have previously developed <italic toggle="yes">A. hydrophila</italic> strain called <italic toggle="yes">23-C-23</italic> with high-level colistin resistance (colistin MIC, 256 &#181;g/mL) by serial passage of clinical colistin-susceptible <italic toggle="yes">A. hydrophila</italic> strain <italic toggle="yes">WCX23</italic> (colistin MIC, 1 &#181;g/mL), which was isolated from farm-raised <italic toggle="yes">Deinagkistrodon acutus</italic> snakes during a fatal diarrhea outbreak in China (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). <italic toggle="yes">23-C-23</italic> was also a multi-drug-resistant <italic toggle="yes">A. hydrophila</italic> strain due to significantly high MICs of many conventional antibiotics against it, while the antibacterial activity of D-Q7 (MIC = 4 &#181;g/mL) against <italic toggle="yes">23-C-23</italic> is much more potent than colistin and other conventional antibiotics (<xref rid="T1" ref-type="table">Table 1</xref>). When <italic toggle="yes">23-C-23</italic> was treated with sub-MIC of D-Q7 for 4 and 8 hours and subjected to transmission electron microscope with high resolution, cell shrinkage and cell wall damage with organelles leakage of <italic toggle="yes">23-C-23</italic> were observed (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). Subsequently, we determined if reactive oxygen species (ROS) production is involved in D-Q7-induced bacteria death, given that ROS can damage a variety of macromolecules, including nucleic acids, proteins, and lipids, and compromise cell viability (<xref rid="B13" ref-type="bibr">13</xref>). Our results revealed that both <italic toggle="yes">WCX23</italic> and <italic toggle="yes">23-C-23</italic> produced significantly higher levels of ROS with D-Q7 treatment (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). Besides, we found that ATP production by both strains was obviously reduced with this peptide treatment, consistent with overall decreased bacteria viability (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). To further verify the mechanism of D-Q7 disrupting bacterial cell membranes, we investigated the effects of various components including phosphatidylglycerol (PG), phosphatidylcholine (PC), and lipopolysaccharide (LPS) in bacterial outer membranes on the antimicrobial efficacy of D-Q7 by using the exogenous addition method (<xref rid="B14" ref-type="bibr">14</xref>). The results indicated that the activity of D-Q7 against <italic toggle="yes">23-C-23</italic> gradually decreased with the increased PG or LPS concentrations. Specifically, the MIC of D-Q7 increased 4-fold and 16-fold when the concentration of exogenous LPS and PG reached 200 &#181;g/mL, respectively. By contrast, the addition of exogenous PC decreased the MIC value of D-Q7. These results suggested that positively charged D-Q7 could selectively interact with negatively charged PG and LPS on the bacterial outer membrane, leading to rupture of the cell membrane and ultimately bacterial cell death, and that the addition of exogenous PC might mediate micellar interactions to improve peptide molecule accessibility, which enhances D-Q7 activity against <italic toggle="yes">23-C-23</italic>. Collectively, these findings indicated that D-Q7 could potently sterilize colistin-resistant <italic toggle="yes">A. hydrophila 23-C-23 in vitro</italic>.</p><table-wrap position="float" id="T1" orientation="portrait"><label>TABLE 1</label><caption><p>Minimum inhibitory concentration (MIC) of D-Q7 and antibiotics against different <italic toggle="yes">Aeromonas hydrophila</italic> strains</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" valign="top" colspan="1" rowspan="1">Strain</th><th align="center" valign="top" colspan="9" rowspan="1">MIC (&#181;g/mL) of D-Q7</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">
<italic toggle="yes">23-C-23</italic>
</td><td align="center" valign="top" colspan="9" rowspan="1">4</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">
<italic toggle="yes">23-C-23:&#916;gene3832</italic>
</td><td align="center" valign="top" colspan="9" rowspan="1">1</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">
<italic toggle="yes">23-C-23:C&#916;gene3832</italic>
</td><td align="center" valign="top" colspan="9" rowspan="1">4</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">
<italic toggle="yes">23-C-23:&#916;envZ/ompR</italic>
</td><td align="center" valign="top" colspan="9" rowspan="1">0.5</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">
<italic toggle="yes">EGCT42</italic>
</td><td align="center" valign="top" colspan="9" rowspan="1">4</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">
<italic toggle="yes">RTF13</italic>
</td><td align="center" valign="top" colspan="9" rowspan="1">8</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">
<italic toggle="yes">WWO29</italic>
</td><td align="center" valign="top" colspan="9" rowspan="1">8</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">
<italic toggle="yes">23-C-23</italic>
</td><td align="center" valign="top" colspan="9" rowspan="1">
<bold>MIC (&#181;g/mL) of antibiotic:</bold>
</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Penicillin</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Lincomycin</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Streptomycin</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Kanamycin</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Gentamicin</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Tetracycline</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Erythromycin</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Azithromycin</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>Cefradine</bold>
</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">4,096</td><td align="left" valign="top" colspan="1" rowspan="1">512</td><td align="left" valign="top" colspan="1" rowspan="1">4,096</td><td align="left" valign="top" colspan="1" rowspan="1">2,048</td><td align="left" valign="top" colspan="1" rowspan="1">16</td><td align="left" valign="top" colspan="1" rowspan="1">8</td><td align="left" valign="top" colspan="1" rowspan="1">16</td><td align="left" valign="top" colspan="1" rowspan="1">32</td><td align="left" valign="top" colspan="1" rowspan="1">512</td></tr></tbody></table></table-wrap><fig position="float" fig-type="figure" id="F1" orientation="portrait"><label>Fig 1</label><caption><p>D-Q7 has significant sterilizing activity against colistin-resistant <italic toggle="yes">A. hydrophila 23-C-23</italic>. (<bold>A</bold>) Colistin-resistant <italic toggle="yes">A. hydrophila 23-C-23</italic> was treated with 1 &#181;g/mL D-Q7 for 4 and 8 hours, then the bacteria were observed by transmission electron microscope (TEM). <italic toggle="yes">WCX23</italic> and <italic toggle="yes">23-C-23</italic> were treated with 2 &#181;g/mL D-Q7 or vehicle control (Ctr), then reactive oxygen species (ROS) and bacteria ATP were measured (<bold>B</bold>) and (<bold>C</bold>). (<bold>D</bold>) Effects of exogenous addition of phosphatidylglycerol (PG), phosphatidylcholine (PC), and lipopolysaccharide (LPS) (0&#8211;200 &#181;g/mL) on the anti-23-C-23 activity of D-Q7, respectively. (<bold>E</bold>) A murine epicutaneous infection model was established. 23-C-23 inoculation after D-Q7 treatment was set as the prevention group; D-Q7 treatment after 23-C-23 inoculation was set as the therapeutic group. (<bold>F</bold>) On day 5, the skin infected on mice was extracted, determining the bacterial load. For (B, C, F) (n=3), values are expressed as mean &#177; SD. Compared with blank, *<italic toggle="yes">P</italic> &lt; 0.05, **<italic toggle="yes">P</italic> &lt; 0.01, ***<italic toggle="yes">P</italic> &lt; 0.001, ****<italic toggle="yes">P</italic> &lt; 0.0001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="spectrum.00590-25.f001.jpg"><alt-text>Transmission micrographs depict bacterial changes from 0 to 8 hours. Bar charts quantify ROS and ATP under treatments. Line graph tracks phospholipid and LPS uptake. Diagram outlines mouse experiment. Bar chart compares bacterial loads across groups.</alt-text></graphic></fig><p>Considering the promising activity of D-Q7 against <italic toggle="yes">23-C-23 in vitro</italic>, we sought to determine its function as an effective antibiotic <italic toggle="yes">in vivo</italic>. We opted for topical application of D-Q7 and established a murine epicutaneous infection model in Kunming mice infected intradermally with <italic toggle="yes">23-C-23</italic>. The bacteria burden was determined by homogenizing the skin lesion with infection and plating samples on tryptone soy agar (TSA) plates on day 5. Topical application of 4 mg/mL D-Q7 on skin lesion after mice infection was set as the prophylactic group. While in the therapeutic group, mice were first infected with bacteria, and topical application of 4 mg/mL D-Q7 was conducted after 4 hours (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). The results showed that compared with vehicles (no treatment after infection), both prophylactic and therapeutic groups had significantly lowered the bacteria burden, with the prophylactic group presenting the lowest burden (<xref rid="F1" ref-type="fig">Fig. 1E</xref>). Overall, these results indicated that low-dose D-Q7 had a long-lasting anti-<italic toggle="yes">23-C-23</italic> effect in an animal wound model.</p><p>Subsequently, to elucidate the mode of action of D-Q7 against <italic toggle="yes">23-C-23</italic>, we treated both <italic toggle="yes">WCX23</italic> and <italic toggle="yes">23-C-23</italic> strains with sub-MIC of D-Q7 for 4 and 8 hours, respectively, and bacterial RNA was extracted for sequencing. Transcriptomics analysis revealed that peptide incubation with either strain caused apparent alteration of gene expression as evidenced by the differentially expressed genes (DEGs) between the blank control and peptide-treated groups. Collectively, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that these genes are enriched in a variety of metabolic pathways and are particularly enriched in ABC transporter proteins, which are a series of transmembrane transporter systems designed to transport a wide range of molecules either across membranes into or export a wide range of molecules, including antibiotics, sugars, and lipids (<xref rid="B15" ref-type="bibr">15</xref>) (<xref rid="F2" ref-type="fig">Fig. 2A and B</xref>). Given that the disruption of bacterial membranes is the most conventional mechanism underlying bacterial killing by AMPs such as colistin (<xref rid="B16" ref-type="bibr">16</xref>), we focused on transmembrane proteins. Specifically, we found <italic toggle="yes">gene3832</italic>, whose expression was reported to modulate membrane permeability as porin protein, was significantly upregulated after treatment with D-Q7 (<xref rid="F2" ref-type="fig">Fig. 2C</xref>). Consistently, quantitative real-time PCR (qRT-PCR) analysis revealed that exposure to D-Q7 induced significant upregulation of gene3832 expression across four distinct <italic toggle="yes">A. hydrophila</italic> isolates (<italic toggle="yes">23-C-23</italic>, <italic toggle="yes">EGCT42</italic>, <italic toggle="yes">RTF13</italic>, and <italic toggle="yes">WWO29</italic>) (<xref rid="F2" ref-type="fig">Fig. 2F</xref>). This conserved transcriptional response among genetically diverse strains strongly suggested that <italic toggle="yes">gene3832</italic> may encode a previously uncharacterized stress-response element associated with AMP exposure. Thus, we deduced that the upregulation of <italic toggle="yes">gene3832</italic> could decrease membrane permeability, a potential defense mode in response to external stimuli such as D-Q7 for bacterial survival (<xref rid="B17" ref-type="bibr">17</xref>).</p><fig position="float" fig-type="figure" id="F2" orientation="portrait"><label>Fig 2</label><caption><p><italic toggle="yes">Gene3832</italic> is involved in D-Q7 activity against <italic toggle="yes">23-C-23</italic> strain. <italic toggle="yes">23-C-23</italic> strains were treated with 1 &#181;g/mL D-Q7 for 4 and 8 hours, and the RNA was extracted for sequencing. KEGG analyses were shown for 4-hour (<bold>A</bold>) and 8-hour (<bold>B</bold>) treatment, respectively. (<bold>C</bold>) Heat map was shown for the transcriptional level change of <italic toggle="yes">23-C-23</italic> and <italic toggle="yes">WXC23</italic> strains for specific genes with D-Q7 treatment for 4 or 8 hours. (<bold>D</bold>) Strain 23-C-23:&#916;3832, wild-type 23-C-23, and 23-C-23:C&#916;3832 exhibit marked alterations in membrane permeability. (<bold>E</bold>) Strain 23-C-23:&#916;3832, wild-type 23-C-23 and 23-C-23:C&#916;3832 undergo altered biofilm formation capacity after D-Q7 treatment. (<bold>F</bold>) Relative transcriptional levels of gene3832 in different <italic toggle="yes">Aeromonas hydrophila</italic> strains treated with D-Q7 as determined by quantitative RT-PCR. For (D, E, F) (n=3), values are expressed as mean &#177; SD. Compared with blank, *<italic toggle="yes">P</italic> &lt; 0.05, **<italic toggle="yes">P</italic> &lt; 0.01, ***<italic toggle="yes">P</italic> &lt; 0.001, ****<italic toggle="yes">P</italic> &lt; 0.0001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="spectrum.00590-25.f002.jpg"><alt-text>Dot plots depict KEGG pathway enrichment under two conditions, with metabolic and signaling changes. Heatmap compares gene expression fold changes. Bar charts quantify membrane permeability, biofilm formation, and gene 3832 expression across treatments.</alt-text></graphic></fig><p>To validate the function of <italic toggle="yes">gene3832</italic> in defending the attack from D-Q7, we knocked out <italic toggle="yes">gene3832</italic> in <italic toggle="yes">23-C-23</italic> (<italic toggle="yes">23-C-23:&#916;3832</italic>) and also complemented <italic toggle="yes">gene3832</italic> back in the knockout strain (<italic toggle="yes">23-C-23:C&#916;3832</italic>). We subjected these different <italic toggle="yes">23-C-23</italic> strains to D-Q7 and found that the MIC for <italic toggle="yes">23-C-23:&#916;3832</italic> was 1 &#181;g/mL, lower than wild-type <italic toggle="yes">23-C-23</italic> and <italic toggle="yes">23-C-23:C3832</italic> (4 &#181;g/mL) (<xref rid="T1" ref-type="table">Table 1</xref>). Correspondingly, strain 23-C-23:&#916;3832 demonstrated markedly increased membrane permeability relative to the wild-type 23-C-23 and 23-C-23:C&#916;3832 (<xref rid="F2" ref-type="fig">Fig. 2D</xref>). <italic toggle="yes">EnvZ/OmpR</italic> can modulate the outer-membrane porins such as OmpF and OmpC in response to adverse stimuli for self-protection, and it was recently reported to regulate the expression of <italic toggle="yes">gene3832</italic> to decrease outer membrane permeability in response to colistin (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B18" ref-type="bibr">18</xref>). Therefore, we also tested D-Q7 activity against the <italic toggle="yes">EnvZ/OmpR</italic> knockout <italic toggle="yes">23-C-23</italic> strain and found the MIC was only 0.5 &#181;g/mL, much lower than wild-type <italic toggle="yes">23-C-23</italic> (<xref rid="T1" ref-type="table">Table 1</xref>). These results were consistent with our deduction that the mode of antibacterial effect of D-Q7 was membrane disruption, in which the expression of gene3832 as an autotransporter might decrease membrane permeability as a potential defense mode. In addition, to further investigate the function of <italic toggle="yes">gene3832</italic> in <italic toggle="yes">23-C-23</italic>, we compared biofilm formation ability between these three strains (<italic toggle="yes">23-C-23</italic>; <italic toggle="yes">23-C-23:&#916;3832</italic>; <italic toggle="yes">23-C-23:C&#916;3832</italic>). The results showed that <italic toggle="yes">gene3832</italic> knock-out <italic toggle="yes">23-C-23</italic> had decreased biofilm ability compared with other strains after D-Q7 treatment (<xref rid="F2" ref-type="fig">Fig. 2E</xref>). Collectively, these results indicated that <italic toggle="yes">gene3832</italic> participated in <italic toggle="yes">23-C-23</italic> survival and growth, suggesting <italic toggle="yes">gene3832</italic> as a potential target for the development of new agents to combat MDR <italic toggle="yes">A. hydrophila</italic> infection in the future.</p><p>In summary, we present our findings that D-Q7 is a potent antibacterial agent that kills colistin-resistant <italic toggle="yes">A. hydrophila 23-C-23 in vitro</italic>, and it has extraordinarily antibacterial efficacy in the mouse epicutaneous model of <italic toggle="yes">23-C-23</italic> infection. Mechanistic studies revealed that D-Q7 interacts with PG and LPS on the bacterial cell membrane and induces an increase in intracellular ROS levels and a decrease in ATP, leading to cell membrane rupture and bacterial death. RNA sequencing of D-Q7-treated <italic toggle="yes">23-C-23</italic> identified several genes as potential targets. Specifically, <italic toggle="yes">gene3832</italic>, a transmembrane autotransporter as predicted, is associated with bacteria resistance to this peptide. The knockout of <italic toggle="yes">gene3832</italic> endows <italic toggle="yes">23-C-23</italic> with greater susceptibility to D-Q7, while <italic toggle="yes">gene3832</italic> complementation restores the antimicrobial effect of this peptide against <italic toggle="yes">23-C-23</italic>. Importantly, we found the presence of <italic toggle="yes">gene3832</italic> in <italic toggle="yes">23-C-23</italic> maintained biofilm formation and membrane permeability of this colistin-resistant <italic toggle="yes">A. hydrophila</italic> strain. Our study first provided a promising peptide lead compound for the development of colistin-resistant <italic toggle="yes">A. hydrophila</italic> drugs and demonstrated that <italic toggle="yes">gene3832</italic> in <italic toggle="yes">A. hydrophila</italic> may act as a potential resistance regulator to modulate bacterial resistance to drugs.</p><sec id="s1-1"><title>Strains, plasmids, and peptide</title><p>The <italic toggle="yes">A. hydrophila</italic> strain <italic toggle="yes">WCX23</italic> was isolated from a snake with fatal diarrhea in the city of Wangcheng, Hunan province in 2017 and was identified as ST516 via multilocus sequence typing; the MDR <italic toggle="yes">A. hydrophila</italic> strain <italic toggle="yes">23-C-23</italic> was selected in the susceptible <italic toggle="yes">A. hydrophila WCX23</italic> strain by serial daily passages on TSA with increasing concentrations of colistin sulfate; the <italic toggle="yes">A. hydrophila</italic> strains <italic toggle="yes">EGCT42</italic>, <italic toggle="yes">RTF13</italic>, and <italic toggle="yes">WWO29</italic> used in this study were isolated from environmental water sample, sick bullfrog, and sick seabass, respectively, collected by our laboratory (Hunan Engineering Research Center of Veterinary Drug, Changsha, Hunan, China). The mutant strains (<italic toggle="yes">23-C-23:&#916;EnvZ/OmpR</italic> and <italic toggle="yes">23-C-23:&#916;gene3832</italic>) and the complemented strain (<italic toggle="yes">23-C-23:C&#916;gene3832</italic>) were constructed in our previously published work. In brief, <italic toggle="yes">23-C-23:&#916;EnvZ/OmpR</italic> and <italic toggle="yes">23-C-23:&#916;gene3832</italic> were generated by deleting the EnvZ/OmpR operon and gene3832, respectively, from the parental strain <italic toggle="yes">23-C-23</italic>, whereas <italic toggle="yes">23-C-23:C&#916;gene3832</italic> is the <italic toggle="yes">23-C-23:&#916;gene3832</italic> knockout complemented with a functional copy of <italic toggle="yes">gene3832</italic>. The construction methods and relevant characteristics of these strains are described in detail in our earlier publication (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B15" ref-type="bibr">15</xref>). All strains were grown on TSA (Oxoid, Basingstoke, UK) or cultured in tryptone soy broth (TSB; Oxoid, Basingstoke, UK at 28&#176;C. Peptide D-Q7 was purchased from GL Biochem Ltd. (Shanghai). All the antibiotics used in this study were purchased from MCE Ltd (Monmouth Junction, NJ, USA).</p></sec><sec id="s1-2"><title>Determination of minimal inhibitory concentration (MIC)</title><p>The minimal inhibitory concentration of D-type polypeptide (D-Q7) against <italic toggle="yes">A. hydrophila</italic> was determined using the micro broth dilution method recommended by the Clinical and Laboratory Standards Institute (CLSI), USA. The bacterial concentration was adjusted to 10<sup>5</sup> CFU/mL using a turbidimeter. Then, 100 &#181;L of drug was added to wells 1&#8211;10 of the 96-well plate, while 100 &#181;L of Muller-Hinton Broth (MHB) was added to wells 11&#8211;12. Subsequently, 100 &#181;L of bacterial suspension was added to wells 1&#8211;12. The plates were then incubated at 28&#8451; for 16&#8211;24 hours, and the results were observed. The MIC results were interpreted based on the CLSI MD100-ED30 (2024) guidelines. Three biological replicates were performed.</p></sec><sec id="s1-3"><title>Transmission electron microscopy</title><p>The concentration of <italic toggle="yes">A. hydrophila</italic> was adjusted to 10<sup>5</sup> CFU/mL using a turbidimeter. The bacteria were treated with 1 mg/L D-Q7 for 4 hours, then resuspended, washed twice with phosphate-buffered saline (PBS), and centrifuged at 8,000 rpm for 10 minutes. The supernatant was discarded, and the bacterial pellet was fixed overnight at 4&#176;C in tissue fixative and analyzed by transmission electron microscopy (Hitachi, HT7800).</p></sec><sec id="s1-4"><title>Reactive oxygen species (ROS) measurement</title><p>The ROS level in bacteria was measured using a ROS detection kit(S0033M) (Beyotime Biotechnology, Shanghai, China). <italic toggle="yes">A. hydrophila</italic> was cultured until OD600 nm = 0.5, then 0.25&#215; MIC, 0.5&#215; MIC, and 1&#215; MIC D-Q7 were added, mixed, and incubated for 1 hour. After incubation, the 2&#8242;,7&#8242;-dichlorofluorescein diacetate probe was loaded for 30 minutes with shaking every 3 minutes. After loading, the probe was washed three times with 1&#215; PBS, and the ROS levels were measured using excitation at 488 nm and emission at 525 nm. Three biological replicates were performed for each group.</p></sec><sec id="s1-5"><title>Effect of bacterial cell membrane components on the anti-<italic toggle="yes">23-C-23</italic> activity of D-Q7</title><p>The checkerboard broth dilution method was used to study the effect of bacterial cell membrane components on the antimicrobial efficacy of D-Q7. D-Q7 was prepared as a stock solution of 1,024 &#181;g/mL in sterile water. The lipids (PC and PG) were purchased from AVT (Shanghai) Pharmaceutical Technology Co., Ltd. First, different concentrations of D-Q7, PC, LPS, and PG were added into 96-well plates, and then 100 &#181;L of <italic toggle="yes">23-C-23</italic> bacterial suspension (1 &#215; 10<sup>5</sup> CFU/mL) was added, and the results were read after incubation at 28&#176;C for 16&#8211;24 hours. MHB was used as a negative control, and <italic toggle="yes">23-C-23</italic> bacterial suspension was used as a positive control.</p></sec><sec id="s1-6"><title>ATP measurement</title><p>The bacterial ATP level was measured using an enhanced ATP assay kit (S0027) (Beyotime Biotechnology, Shanghai, China). <italic toggle="yes">A. hydrophila</italic> was cultured until OD600 nm = 0.5, then 0.25&#215; MIC, 0.5&#215; MIC, and 1&#215; MIC D-Q7 were added, mixed, and incubated at 28&#176;C for 1 hour. After incubation, the bacteria were washed three times with 1&#215; PBS, centrifuged, and resuspended. The bacterial suspension was treated with 200 &#181;L of 15 mg/mL lysozyme, vortexed, and the supernatant was collected. The sample and detection reagent were mixed in a 1:1 ratio in a black 96-well plate and measured using a luminometer. Three biological replicates were set for each group.</p></sec><sec id="s1-7"><title>Transcriptome analysis</title><p>Briefly, the strains were cultured to log-phase (OD600 nm =&#8201;0.6 &#177;&#8201;0.05) at 28&#176;C, and then the cells were harvested and washed twice by sterilized PBS. Total RNA was extracted using Qiagen RNeasy Mini kits (Qiagen, Hilden, Germany) and quantified using a NanoDrop 2000 spectrophotometer (Thermo Fisher, Waltham, MA, USA). rRNA was depleted, and cDNA libraries were prepared. The cDNA libraries were further sequenced by the Illumina Hiseq 2000 system (Majorbio, Shanghai, China). DEGs were identified by gene expression-level analysis using the Fragments Per Kilobase of transcript per Million mapped reads method with <italic toggle="yes">P</italic>-values &#8804; 0.05 and fold change (FC) values &#8805; 2 (log2<sub>2</sub> FC &#8805;1 or log2<sub>2</sub> FC &#8804; &#8722;1). Gene Ontology and KEGG enrichment pathway analysis of DEGs was performed using the R package (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bioconductor.org/packages/edgeR" ext-link-type="uri">https://bioconductor.org/packages/edgeR</ext-link>).</p></sec><sec id="s1-8"><title>Animals and treatments</title><p>Experimental animals were obtained from Hunan SJA Laboratory Animal Co., Ltd. Kunming mice were acclimated for one week in a controlled environment with a 12-hour light/dark cycle, a relative humidity of 60% &#177; 10%, and a temperature of 24 &#177; 2&#8451;. All mice were anesthetized using tribromoethanol. The mice (6&#8211;8 weeks old) were weighed and randomly assigned to four groups, each consisting of eight mice: a blank group, a model group, a prophylactic group, and a therapeutical group. The mice were anesthetized, and a 5 mm diameter wound was created on the mid-back using ophthalmic forceps and iris scissors. For the blank group, we did not infect <italic toggle="yes">23-C-23</italic> on the wound or apply any drugs. For the model group, we infected the wound with 10 &#181;L suspension of <italic toggle="yes">23-C-23</italic> (at a concentration of 10<sup>8</sup> CFU/mL) without any drug treatment. For the prophylactic group of mice, we applied 10 &#181;l of 4 mg/mL D-Q7 to circular wounds in advance at the wound site, and after 1 hour, we applied a 10 &#181;L suspension of <italic toggle="yes">23-C-23</italic> (at a concentration of 10<sup>8</sup> CFU/mL) to infect the circular wounds of mice. For the therapeutical group, we infected the wound with 10 &#181;L suspension of <italic toggle="yes">23-C-23</italic> (at a concentration of 10<sup>8</sup> CFU/mL), and after 4 hours, 10 &#181;L 4 mg/mL D-Q7 was added onto the circular wound.</p></sec><sec id="s1-9"><title>Measurement of bacterial counts at the wound site</title><p>On the 5th day of treatment, four mice were randomly selected from each group and euthanized. A square piece of skin tissue 1 &#215; 1 cm&#178;, centered on the wound, was excised using surgical scissors and placed in a 2 mL grinding tube containing 1 mL of physiological saline and grinding beads. The tissue was subjected to 60 Hz shaking and grinding for 180 seconds, followed by the collection of the supernatant. After gradient dilution, the supernatant was evenly plated on TSA medium containing 8 &#181;g/mL colistin. The tissue was incubated at 28&#176;C for 16&#8211;24 hours, and the bacterial count of <italic toggle="yes">23-C-23</italic> in the wound tissue was determined.</p></sec><sec id="s1-10"><title>Biofilm formation assay</title><p>The strains were cultured to log-phase (OD600 nm =&#8201;0.6 &#177;&#8201;0.05) at 28&#176;C, and adjusted to an OD 600 nm of 0.1, and 200 &#181;L of culture (1:100 dilution) was dispensed into 96-well plates and incubated at 28&#176;C. A 200 &#181;L aliquot of fresh TSB was added to the plates as a blank control. After 24-hour incubation, the medium was discarded, and the plates were washed three times with sterile PBS. The biofilm was fixed with 200 &#181;L of methanol for 15 minutes and incubated with 200 &#181;L of 1% crystal violet for 15 minutes. After several washes with ddH2<sub>2</sub>O and air-dried, the dried biofilm was solubilized in 200 &#181;L 95% ethanol for 10&#8201;minutes. The absorbance was measured at 595 nm.</p></sec><sec id="s1-11"><title>Determination of bacterial outer membrane permeability</title><p>N-Phenyl-1-naphthylamine (NPN) was used to assess the integrity of the outer membranes of <italic toggle="yes">23-C-23</italic>. The bacterial suspension was diluted 1:100 in LB broth and incubated at 28&#176;C until reaching an OD600nm of 0.6. The cells were then centrifuged, resuspended, and the OD600nm was adjusted to 0.5 using PBS. NPN was added at a final concentration of 10 &#181;M, and the mixture was incubated for 30 minutes at 28&#176;C in the dark. Added final concentration of 0.25&#215; MIC, 0.5&#215; MIC, and 1&#215; MIC D-Q7 incubated for 1 hour. Fluorescence intensity was measured using a fluorescence plate reader with excitation wavelengths of 350 nm and emission wavelengths of 420 nm (NPN). Three biological replicates were prepared. NPN (P110559) was purchased from Aladdin Biochemical Technology, Shanghai, China.</p></sec><sec id="s1-12"><title>Statistical analyses</title><p>All the experiments were tested at least three times. All data were expressed as the mean &#177;&#8201;SD. Student&#8217;s <italic toggle="yes">t</italic>-test and analysis of variance were used to process and analyze routine data. <italic toggle="yes">P</italic> &#8201;&lt;&#8201; 0.05 represents statistically significant.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="d101e350" position="float" orientation="portrait"><caption><title>Reviewer comments</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="reviewer-comments.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This work was supported by the Hunan Natural Science Foundation (2023JJ30301) and the Hunan Provincial Key Laboratory of Anti-Resistance Microbial Drugs, the Third Hospital of Changsha (No: 2023TP1013).</p></ack><sec sec-type="ethics" id="s2-1"><title>ETHICS APPROVAL</title><p>All experimental procedures and sample collections were conducted in accordance with the Chinese Animal Welfare Guidelines and approved by the Institutional Animal Care and Use Committee of Hunan Agricultural University.</p></sec><sec sec-type="supplementary-material" id="s2-2"><title>SUPPLEMENTAL MATERIAL</title><p specific-use="print-only">The following material is available online at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1128/spectrum.00590-25" ext-link-type="uri">https://doi.org/10.1128/spectrum.00590-25</ext-link>.</p><supplementary-material id="SuF1" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1128/spectrum.00590-25.SuF1</object-id><label>OPEN PEER REVIEW</label><caption><title>reviewer-comments.pdf</title><p>An accounting of the reviewer comments and feedback.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="reviewer-comments.pdf" position="float" orientation="portrait"/></supplementary-material><p specific-use="online-only">ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse. </p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Stratev</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Odeyemi</surname><given-names>OA</given-names></string-name></person-group>. <year>2016</year>. <article-title>Antimicrobial resistance of Aeromonas hydrophila isolated from different food sources: A mini-review</article-title>. <source>J Infect Public Health</source><volume>9</volume>:<fpage>535</fpage>&#8211;<lpage>544</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jiph.2015.10.006</pub-id><pub-id pub-id-type="pmid">26588876</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Citterio</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Francesca</surname><given-names>B</given-names></string-name></person-group>. <year>2015</year>. <article-title>Aeromonas hydrophila virulence</article-title>. <source>Virulence</source><volume>6</volume>:<fpage>417</fpage>&#8211;<lpage>418</lpage>. doi:<pub-id pub-id-type="doi">10.1080/21505594.2015.1058479</pub-id><pub-id pub-id-type="pmid">26055576</pub-id><pub-id pub-id-type="pmcid">PMC4601520</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alonso-Gonz&#225;lez</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Gallego-Rodrigo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Barrios-Andr&#233;s</surname><given-names>JL</given-names></string-name></person-group>. <year>2023</year>. <article-title>Multiresistant Aeromonas hydrophila bacteremia</article-title>. <source>Enfermedades infecciosas y microbiologia clinica (English ed.)</source><volume>41</volume>:<fpage>247</fpage>&#8211;<lpage>248</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eimce.2023.02.004</pub-id><pub-id pub-id-type="pmid">36870822</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Qiu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Olsen</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>Meng</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name></person-group>. <year>2025</year>. <article-title>Environmental concentrations of antibiotics induced polymyxin B tolerance in Aeromonas hydrophila</article-title>. <source>Science of The Total Environment</source><volume>959</volume>:<fpage>178247</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.scitotenv.2024.178247</pub-id><pub-id pub-id-type="pmid">39721523</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bin Hafeez</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Bergen</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name></person-group>. <year>2021</year>. <article-title>Antimicrobial peptides: an update on classifications and databases</article-title>. <source>Int J Mol Sci</source><volume>22</volume>:<fpage>21</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms222111691</pub-id><pub-id pub-id-type="pmcid">PMC8583803</pub-id><pub-id pub-id-type="pmid">34769122</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zuo</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name></person-group>. <year>2022</year>. <article-title>Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides</article-title>. <source>Molecules</source><volume>27</volume>:<fpage>2675</fpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules27092675</pub-id><pub-id pub-id-type="pmid">35566025</pub-id><pub-id pub-id-type="pmcid">PMC9104849</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boparai</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Sharma</surname><given-names>PK</given-names></string-name></person-group>. <year>2020</year>. <article-title>Mini review on antimicrobial peptides, sources, mechanism and recent applications</article-title>. <source>Protein Pept Lett</source><volume>27</volume>:<fpage>4</fpage>&#8211;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.2174/0929866526666190822165812</pub-id><pub-id pub-id-type="pmid">31438824</pub-id><pub-id pub-id-type="pmcid">PMC6978648</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zeng</surname><given-names>Z-Z</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>S-H</given-names></string-name>, <string-name name-style="western"><surname>Alezra</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Wan</surname><given-names>Y</given-names></string-name></person-group>. <year>2021</year>. <article-title>Antimicrobial peptides: triumphs and challenges</article-title>. <source>Future Med Chem</source><volume>13</volume>:<fpage>1313</fpage>&#8211;<lpage>1315</lpage>. doi:<pub-id pub-id-type="doi">10.4155/fmc-2021-0134</pub-id><pub-id pub-id-type="pmid">34148371</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Starr</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>Ghimire</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Guha</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hoffmann</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Landreneau</surname><given-names>BN</given-names></string-name>, <string-name name-style="western"><surname>Kolansky</surname><given-names>ZD</given-names></string-name>, <string-name name-style="western"><surname>Kilanowski-Doroh</surname><given-names>IM</given-names></string-name>, <string-name name-style="western"><surname>Sammarco</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Morici</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Wimley</surname><given-names>WC</given-names></string-name></person-group>. <year>2020</year>. <article-title>Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria</article-title>. <source>Proc Natl Acad Sci USA</source><volume>117</volume>:<fpage>8437</fpage>&#8211;<lpage>8448</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1918427117</pub-id><pub-id pub-id-type="pmid">32241895</pub-id><pub-id pub-id-type="pmcid">PMC7165445</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ghimire</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hart</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Soldano</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Guha</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hoffmann</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Nelson</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>TK</given-names></string-name>, <string-name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Rivera</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Morici</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Wimley</surname><given-names>WC</given-names></string-name></person-group>. <year>2023</year>. <article-title>Optimization of host cell-compatible, antimicrobial peptides effective against biofilms and clinical isolates of drug-resistant bacteria</article-title>. <source>ACS Infect Dis</source><volume>9</volume>:<fpage>952</fpage>&#8211;<lpage>965</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acsinfecdis.2c00640</pub-id><pub-id pub-id-type="pmid">36961222</pub-id><pub-id pub-id-type="pmcid">PMC10111420</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>X</given-names></string-name></person-group>. <year>2019</year>. <article-title>A fatal diarrhoea outbreak in farm-raised Deinagkistrodon acutus in China is newly linked to potentially zoonotic Aeromonas hydrophila</article-title>. <source>Transbound Emerg Dis</source><volume>66</volume>:<fpage>287</fpage>&#8211;<lpage>298</lpage>. doi:<pub-id pub-id-type="doi">10.1111/tbed.13020</pub-id><pub-id pub-id-type="pmid">30222905</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Z</given-names></string-name></person-group>. <year>2021</year>. <article-title>Various novel colistin resistance mechanisms interact to facilitate adaptation of Aeromonas hydrophila to complex colistin environments</article-title>. <source>Antimicrob Agents Chemother</source><volume>65</volume>:<elocation-id>e0007121</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00071-21</pub-id><pub-id pub-id-type="pmid">33903105</pub-id><pub-id pub-id-type="pmcid">PMC8373241</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ezraty</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Gennaris</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Barras</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Collet</surname><given-names>J-F</given-names></string-name></person-group>. <year>2017</year>. <article-title>Oxidative stress, protein damage and repair in bacteria</article-title>. <source>Nat Rev Microbiol</source><volume>15</volume>:<fpage>385</fpage>&#8211;<lpage>396</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro.2017.26</pub-id><pub-id pub-id-type="pmid">28420885</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yang</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Qin</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>Y</given-names></string-name></person-group>. <year>2024</year>. <article-title>Novel membrane-targeting isoxanthohumol-amine conjugates for combating methicillin-resistant Staphylococcus aureus (MRSA) infections</article-title>. <source>Eur J Med Chem</source><volume>268</volume>:<fpage>116274</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejmech.2024.116274</pub-id><pub-id pub-id-type="pmid">38408389</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Xiao</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Z</given-names></string-name></person-group>. <year>2022</year>. <article-title>Contribution of the EnvZ/OmpR two-component system to growth, virulence and stress tolerance of colistin-resistant Aeromonas hydrophila</article-title>. <source>Front Microbiol</source><volume>13</volume>:<elocation-id>1032969</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2022.1032969</pub-id><pub-id pub-id-type="pmid">36312957</pub-id><pub-id pub-id-type="pmcid">PMC9597241</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Khavani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mehranfar</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mofrad</surname><given-names>MRK</given-names></string-name></person-group>. <year>2025</year>. <article-title>Antimicrobial peptide interactions with bacterial cell membranes</article-title>. <source>J Biomol Struct Dyn</source><volume>43</volume>:<fpage>4615</fpage>&#8211;<lpage>4628</lpage>. doi:<pub-id pub-id-type="doi">10.1080/07391102.2024.2304683</pub-id><pub-id pub-id-type="pmid">38263741</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Delcour</surname><given-names>AH</given-names></string-name></person-group>. <year>2009</year>. <article-title>Outer membrane permeability and antibiotic resistance</article-title>. <source>Biochim Biophys Acta</source><volume>1794</volume>:<fpage>808</fpage>&#8211;<lpage>816</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbapap.2008.11.005</pub-id><pub-id pub-id-type="pmid">19100346</pub-id><pub-id pub-id-type="pmcid">PMC2696358</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kenney</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Anand</surname><given-names>GS</given-names></string-name></person-group>. <year>2020</year>. <article-title>EnvZ/OmpR two-component signaling: an archetype system that can function noncanonically</article-title>. <source>EcoSal Plus</source><volume>9</volume>. doi:<pub-id pub-id-type="doi">10.1128/ecosalplus.ESP-0001-2019</pub-id><pub-id pub-id-type="pmcid">PMC7192543</pub-id><pub-id pub-id-type="pmid">32003321</pub-id></mixed-citation></ref></ref-list></back></article>